Adult Hematology Abstract CategoriesLymphomaPP 26
From CD5-Negative Indolent B-Cell LPD to Therapy-Related CLL/SLL with Unmutated IGHV After Breast Cancer: Rationale for BTK-Inhibitor–Based First-Line Therapy
Birol Güvenç*
Çukurova University, Dept.of Hematology, Balcali_Adana,Turkiye
